Approximately 23,000 doses of the Ad26.ZEBOV/MVA-BN-Filo vaccine—manufactured by Johnson & Johnson (J&J)—have arrived in the Democratic Republic of Congo (DRC). Trained immunization teams will initially administer the vaccine in two sites, with four more to be set up in the coming weeks. It will be offered to adults and to children aged one and older … Continue reading Johnson & Johnson new Ebola vaccine targets 50,000 people in 4 months